These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
112 related items for PubMed ID: 15044430
1. Pharmacokinetics and safety of itraconazole in patients with cystic fibrosis. Conway SP, Etherington C, Peckham DG, Brownlee KG, Whitehead A, Cunliffe H. J Antimicrob Chemother; 2004 May; 53(5):841-7. PubMed ID: 15044430 [Abstract] [Full Text] [Related]
2. Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy. Boogaerts MA, Maertens J, Van Der Geest R, Bosly A, Michaux JM, Van Hoof A, Cleeren M, Wostenborghs R, De Beule K. Antimicrob Agents Chemother; 2001 Mar; 45(3):981-5. PubMed ID: 11181397 [Abstract] [Full Text] [Related]
3. Effects of cyclosporine a on single-dose pharmacokinetics of intravenous itraconazole in patients with hematologic malignancies. Timmers GJ, Kessels LW, Wilhelm AJ, Veldkamp AI, Bosch TM, Beijnen JH, Huijgens PC. Ther Drug Monit; 2008 Jun; 30(3):301-5. PubMed ID: 18520601 [Abstract] [Full Text] [Related]
4. Pharmacokinetics of intravenous itraconazole followed by itraconazole oral solution in patients with human immunodeficiency virus infection. Zhao Q, Zhou H, Pesco-Koplowitz L. J Clin Pharmacol; 2001 Dec; 41(12):1319-28. PubMed ID: 11762559 [Abstract] [Full Text] [Related]
5. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS. Caillot D, Bassaris H, McGeer A, Arthur C, Prentice HG, Seifert W, De Beule K. Clin Infect Dis; 2001 Oct 15; 33(8):e83-90. PubMed ID: 11550120 [Abstract] [Full Text] [Related]
6. Population pharmacokinetics of itraconazole and its active metabolite hydroxy-itraconazole in paediatric cystic fibrosis and bone marrow transplant patients. Hennig S, Wainwright CE, Bell SC, Miller H, Friberg LE, Charles BG. Clin Pharmacokinet; 2006 Oct 15; 45(11):1099-114. PubMed ID: 17048974 [Abstract] [Full Text] [Related]
7. Itraconazole plasma and tissue concentrations in the spiny lizard (Sceloporus sp.) following once-daily dosing. Gamble KC, Alvarado TP, Bennett CL. J Zoo Wildl Med; 1997 Mar 15; 28(1):89-93. PubMed ID: 9226621 [Abstract] [Full Text] [Related]
8. Pharmacokinetics of itraconazole oral solution in allogeneic bone marrow transplant patients receiving total body irradiation. Michallet M, Persat F, Kranzhöfer N, Levron JC, Prat C, Belhabri A, Chwetzoff E, Le Moing JP, Fiere D, Piens MA. Bone Marrow Transplant; 1998 Jun 15; 21(12):1239-43. PubMed ID: 9674858 [Abstract] [Full Text] [Related]
9. Itraconazole disposition after single oral and intravenous and multiple oral dosing in healthy cats. Boothe DM, Herring I, Calvin J, Way N, Dvorak J. Am J Vet Res; 1997 Aug 15; 58(8):872-7. PubMed ID: 9256973 [Abstract] [Full Text] [Related]
10. Safety and pharmacokinetics of ascending single doses of sirolimus (Rapamune, rapamycin) in pediatric patients with stable chronic renal failure undergoing dialysis. Tejani A, Alexander S, Ettenger R, Lerner G, Zimmerman J, Kohaut E, Briscoe DM. Pediatr Transplant; 2004 Apr 15; 8(2):151-60. PubMed ID: 15049795 [Abstract] [Full Text] [Related]
11. Marked intra- and inter-patient variability of itraconazole steady state plasma concentrations. Poirier JM, Berlioz F, Isnard F, Cheymol G. Therapie; 1996 Apr 15; 51(2):163-7. PubMed ID: 8763051 [Abstract] [Full Text] [Related]
13. Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation. Mouton JW, van Peer A, de Beule K, Van Vliet A, Donnelly JP, Soons PA. Antimicrob Agents Chemother; 2006 Dec 15; 50(12):4096-102. PubMed ID: 16982783 [Abstract] [Full Text] [Related]
14. [Pharmacokinetics of oral theophylline. Comparison between asthmatic and cystic fibrosis patients]. Repetto T, Marianelli L, Valenza T, Rosselli P, Messori A. Pediatr Med Chir; 1985 Dec 15; 7(6):823-5. PubMed ID: 3837249 [Abstract] [Full Text] [Related]
15. Voriconazole pharmacokinetic variability in cystic fibrosis lung transplant patients. Berge M, Guillemain R, Boussaud V, Pham MH, Chevalier P, Batisse A, Amrein C, Dannaoui E, Loriot MA, Lillo-Le Louet A, Billaud EM. Transpl Infect Dis; 2009 Jun 15; 11(3):211-9. PubMed ID: 19302272 [Abstract] [Full Text] [Related]
16. Pharmacokinetic study of memantine in healthy and renally impaired subjects. Periclou A, Ventura D, Rao N, Abramowitz W. Clin Pharmacol Ther; 2006 Jan 15; 79(1):134-43. PubMed ID: 16413248 [Abstract] [Full Text] [Related]
17. Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone. Jaakkola T, Backman JT, Neuvonen M, Neuvonen PJ. Clin Pharmacol Ther; 2005 May 15; 77(5):404-14. PubMed ID: 15900286 [Abstract] [Full Text] [Related]
18. Pharmacokinetics of a guanfacine extended-release formulation in children and adolescents with attention-deficit-hyperactivity disorder. Boellner SW, Pennick M, Fiske K, Lyne A, Shojaei A. Pharmacotherapy; 2007 Sep 15; 27(9):1253-62. PubMed ID: 17723079 [Abstract] [Full Text] [Related]
19. Effect of high-dose vitamin C on the steady-state pharmacokinetics of the protease inhibitor indinavir in healthy volunteers. Slain D, Amsden JR, Khakoo RA, Fisher MA, Lalka D, Hobbs GR. Pharmacotherapy; 2005 Feb 15; 25(2):165-70. PubMed ID: 15767232 [Abstract] [Full Text] [Related]
20. Comparison of the oral pharmacokinetics of fluconazole and itraconazole in Mexicans. Flores-Murrieta FJ, Carrasco-Portugal Mdel C, Landa C. Proc West Pharmacol Soc; 2008 Feb 15; 51():63-5. PubMed ID: 19544680 [Abstract] [Full Text] [Related] Page: [Next] [New Search]